Stock listing
NASDAQ:ARLZ Aralez Pharmaceuticals Inc Stock
Follow Aralez Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted NASDAQ:ARLZ no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ARLZ
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Aralez Pharmaceuticals Inc on 6ix
- Decks
- 4 decks · latest Jun 9, 2016
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Jefferies Healthcare Conference 2016 | Conference | 17 slides | Jun 9, 2016 |
| Bloom Burton Healthcare Conference 2016 | Conference | 15 slides | May 2, 2016 |
| Non-Deal Roadshow (April 2016) | Roadshow | 18 slides | Apr 4, 2016 |
| Cowen Healthcare Conference 2016 | Conference | 16 slides | Mar 7, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Adrian Adams Other companies: Akebia Therapeutics, Inc. (Chairperson · Since at least Dec 12, 2018); Talphera, Inc. (Director · Since at least Feb 11, 2013); Impel Neuropharma Inc (COB, CEO and President, Director · Apr 22, 2021 – Jan 26, 2022 · Past); POZEN Inc (Chief Executive Officer, Director · May 31, 2015 – Nov 11, 2015 · Past); Auxilium Pharmaceuticals Inc (CEO and President, Director · Dec 7, 2011 – Jan 29, 2015 · Past); Inspire Pharmaceuticals Inc (President and CEO, Director · Feb 22, 2010 – May 13, 2011 · Past); Amylin Pharmaceuticals LLC (Director · Oct 29, 2007 – Aug 8, 2012 · Past); Sepracor Inc (President & CEO, Director · Mar 1, 2007 – Oct 20, 2009 · Past); Neurocrine Biosciences, Inc. (Director · Jun 30, 2006 – Jun 30, 2006 · Past); Kos Pharmaceuticals Inc (President & CEO, Director · Jan 26, 2006 – Dec 13, 2006 · Past) | Chief Executive Officer, Director · Feb 5, 2016 – May 11, 2017 · Past |
| Jason M. Aryeh Other companies: Lifecore Biomedical, Inc. (Director · Since at least Aug 15, 2024); Orchestra BioMed Holdings, Inc. (Director · Since at least Jan 26, 2023); Anebulo Pharmaceuticals, Inc. (Board Member · Since at least May 6, 2021); Ligand Pharmaceuticals Incorporated (Director · Since at least May 30, 2007); Immunomedics Inc (Director · Jan 8, 2017 – Jan 8, 2017 · Past); Novelion Therapeutics Inc (Director · Jun 4, 2012 – May 15, 2017 · Past); Myrexis Inc (Director · Oct 19, 2011 – Jun 18, 2012 · Past); Vaxart, Inc. (Director · May 18, 2007 – May 25, 2011 · Past) | Director · Feb 5, 2016 – May 19, 2017 · Past |
| Andrew Koven Other companies: MetaVia Inc. (Chairman of the Board · Since at least Jul 9, 2021); Kala Bio, Inc. (Director · Since at least Sep 28, 2017); POZEN Inc (President, Chief Business Ofc. · May 31, 2015 – Jun 3, 2015 · Past); Auxilium Pharmaceuticals Inc (EVP, CAO, GC and Secretary · Feb 3, 2012 – Jan 29, 2015 · Past); Inspire Pharmaceuticals Inc (EVP & Chief Admin & Legal Ofc · May 10, 2010 – May 13, 2011 · Past); Sepracor Inc (Exec VP, General Counsel · Mar 1, 2007 – Oct 20, 2009 · Past); Kos Pharmaceuticals Inc (EVP, General Counsel · Jan 26, 2006 – Dec 13, 2006 · Past) | President & Chief Business Off · Feb 5, 2016 – Jun 4, 2018 · Past |
| Mark A. Glickman Other companies: BioStem Technologies, Inc. (Director · Since at least Aug 6, 2026); MetaVia Inc. (Independent Director · Since at least May 11, 2023); TherapeuticsMD, Inc. (Co-Chief Executive Officer · Oct 15, 2021 – Dec 6, 2022 · Past); Esperion Therapeutics, Inc. (Chief Commercial Officer · Dec 20, 2018 – Jan 2, 2020 · Past); POZEN Inc (Chief Commercial Officer · Jun 22, 2015 – Jun 22, 2015 · Past); Auxilium Pharmaceuticals Inc (EVP - Sales and Marketing · Feb 3, 2012 – Jan 29, 2015 · Past) | Chief Commercial Officer · Feb 5, 2016 – Mar 19, 2018 · Past |
| James P. Tursi Other companies: MetaVia Inc. (Independent Director · Since at least Nov 1, 2023); Endo International PLC (Executive VP, Global R&D · Feb 24, 2022 – Jul 15, 2022 · Past); Antares Pharma Inc (EVP, Chief Medical Officer · Aug 6, 2018 – Jun 13, 2019 · Past); POZEN Inc (Chief Medical Officer · Oct 1, 2015 – Oct 1, 2015 · Past); Auxilium Pharmaceuticals Inc (Chief Medical Officer · Feb 14, 2012 – Jan 29, 2015 · Past) | Chief Medical Officer · Feb 5, 2016 – May 14, 2018 · Past |
| Arthur Kirsch Other companies: Evommune, Inc. (Audit · Since at least Nov 5, 2025); Atea Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Liquidia Corporation (Board Member · Since at least Mar 24, 2021); Kadmon Holdings Inc (Director · May 15, 2019 – Nov 9, 2021 · Past) | Director · May 12, 2016 – Dec 8, 2017 · Past |
| Seth Rudnick Other companies: G1 Therapeutics Inc (Director · May 16, 2017 – Jun 29, 2021 · Past); Square 1 Financial Inc (Director · Mar 24, 2014 – Oct 6, 2015 · Past); POZEN Inc (Director · Jul 25, 2011 – Jun 23, 2015 · Past); Immunicon Corp (Director · Jan 19, 2006 – Jan 19, 2006 · Past) | Director · Feb 5, 2016 – May 11, 2017 · Past |
| Michael Kaseta Other companies: Heron Therapeutics, Inc. (Director · Since at least Nov 4, 2024); Liquidia Corporation (CFO and COO · Since at least Nov 30, 2020); Alimera Sciences Inc (Director · Mar 24, 2023 – Sep 16, 2024 · Past) | Chief Financial Officer · Nov 30, 2017 – Mar 15, 2018 · Past |
| Neal Fowler Other companies: Emergent BioSolutions Inc. (Independent Director · Since at least Oct 1, 2023); Liquidia Corporation (Chief Executive Officer, Director · Nov 19, 2020 – Nov 19, 2020 · Past); POZEN Inc (Director · Jun 10, 2010 – Jul 28, 2015 · Past) | Director · Feb 5, 2016 – May 11, 2017 · Past |
| Eric Trachtenberg Other companies: Kala Bio, Inc. (SEE REMARKS · Apr 2, 2018 – Jan 4, 2024 · Past); POZEN Inc (Deputy General Counsel · Jun 22, 2015 – Jun 22, 2015 · Past) | GC, CCO & Secretary · Feb 5, 2016 – Mar 19, 2018 · Past |
All 15 people
| Person | Seat |
|---|---|
| Kenneth B Lee Jr Other companies: Hyperion DeFi, Inc. (Director · Mar 26, 2018 – Jun 16, 2022 · Past); BioCryst Pharmaceuticals, Inc. (Director · May 23, 2016 – Jun 13, 2023 · Past) | Director · May 13, 2016 – May 11, 2017 · Past |
| John E Barnhardt Other companies: POZEN Inc (VP, Finance and Administration · Jan 3, 2006 – Dec 31, 2015 · Past) | VP, Finance and Administration · Feb 4, 2016 – Feb 5, 2016 · Past |
| Scott J Charles Other companies: POZEN Inc (Vice President of Finance · Jul 27, 2015 – Jul 27, 2015 · Past) | Chief Financial Officer · Feb 5, 2016 – Jul 28, 2017 · Past |
| francis martin thrasher | Director · Feb 5, 2016 – May 11, 2017 · Past |
| Jennifer Lou Armstrong | EVP HR and Administration · Feb 5, 2016 – May 11, 2017 · Past |
Log in to ask 6ix AI your own questions about Aralez Pharmaceuticals Inc.